Global Liquid Biopsy Market Research Report: Forecast (2023-2028)

By Work Process (Sample Preparation, Library Preparation, Sequencing, Data Analysis), By Technology (PCR [RT-PCR, dPCR, Multiplex PCR, Others], NGS, FISH, Other Technologies), By Usage (RUO, Clinical)... ... sage (RUO, Clinical), By Sample Type (Blood, Urine, Saliva, CerebroSpinal Fluid), By Product (Test /Services, Kits and Consumables, Instruments), By Circulating Biomarkers (Circulating Tumor Cells, Cell-free DNA, Circulating Cell-Free RNA, Exosomes and Extracellular Vesicles, Others), By Disease Type (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Melanoma, Other Cancers, Non-Oncology Disorders), By Clinical Application (Treatment Monitoring, Prognosis and Recurrence Monitoring, Treatment Selection, Diagnosis and Screening), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Mexico, Brazil, UK, Germany, France, Italy, Spain, UAE, Saudi Arabia, South Africa, China, Japan, South Korea, India, South East Asia), By Company (Bio-Rad Laboratories, Biocept Inc, Abcodia Ltd, Chronix Biomedical, Epic Sciences Inc, Hoffmann-La Roche AG, Cynvenio Biosystems, Inc., GUARDANT HEALTH, INC, Illumina, Inc., NeoGenomics Laboratories, Inc., Menarini Silicon Biosystems, Inc., Qiagen N.V., Thermo Fisher Scientific, Personal Genome Diagnostics, Inc., Qiagen N.V. etc.) Read more

  • Healthcare
  • Jun 2023
  • 182
  • PDF, Excel, PPT

Market Definition

Liquid Biopsy is a laboratory test done on a sample of blood, urine, or other body fluids to look for remnants of cancer cells, from tumor to slightest strain, like DNA, RNA, or other molecules released by tumorous cancer cells into the body’s fluids. It can be applied to screen early cancer, track cancer/tumor progression, assess clinical prognosis, detect recurrent tumor cells, and more. It has gained attention and is appreciated as a non-invasive technique as it is less bodily taxing than tissue biopsy due to technological advances.

Market Insights & Analysis: Global Liquid Biopsy Market (2023-28)

The Global Liquid Biopsy Market is projected to grow at a CAGR of around 26% during the forecast period, i.e., 2023-28. The market is significantly driven by the rising cases and prevalence of cancer, along with the increasing awareness and preference for non-invasive treatment procedures. Furthermore, the understanding and appreciation are guided by the several benefits associated with the new liquid biopsy technique, including rapid results, low cost, early prognosis, overcoming tumor heterogeneity, low risk, and non-invasiveness.

In addition, Liquid biopsy is less mentally taxing for the patient than other methods, such as tissue biopsy, resulting in further demand in the market and is expected to significantly drive the need for the market during the forecasting years.

Report Coverage Details
Study Period Historical Data: 2018-21
Base Year: 2022
Forecast Period: 2023-28
CAGR (2023-2028) 26%
Regions Covered North America: The US, Canada, Mexico
Europe: United Kingdom, Germany, France, Spain, Italy, and Others
Asia-Pacific: China, India, Japan, South Korea, South East Asia 
South America: Brazil, and Others
Middle East & Africa: Saudi Arabia, UAE, South Africa 
Key Companies Profiled Bio-Rad Laboratories, Biocept Inc, Abcodia Ltd, Chronix Biomedical, Epic Sciences Inc, Hoffmann-La Roche AG, Cynvenio Biosystems, Inc., GUARDANT HEALTH, INC, Illumina, Inc., NeoGenomics Laboratories, Inc., Menarini Silicon Biosystems, Inc., Qiagen N.V., Thermo Fisher Scientific, Personal Genome Diagnostics, Inc., Qiagen N.V. etc.
Unit Denominations USD Million/Billion

 

Consecutively, the rising preference for market growth is boosted by cancer awareness initiatives as it can monitor tumor progression early, along with eliminating the discomfort associated with the operation. In addition, with the emergence of advanced technologies, the demand for non-invasive diagnosis and treatment is rising. As it offers a non-risk effective alternative to patients, it is expected to spur the need for liquid biopsy in the forecasting period.

Furthermore, due to the inaccessibility of direct laboratories with infrastructures to undertake the liquid biopsy tests of patients in need, the fluid biopsy industry depends on the distance collection of samples by transporting the diagnostic kits to the patient. Therefore, this rising demand for the equipment would also accelerate the demand graph, further enhancing the Global Liquid Biopsy Market size in the future. 

Moreover, developing interest, research, and competition among significant laboratories, clinical industries, and research companies with dedicated investments from private and public organizations to fund the research for better cancer treatments. With the integration of advanced technology into the treatment process, further Market expansion could be expected.

  • In November 2020, NeoGenomics, Inc. launched a mobile phlebotomy service for biopsy tests. It ensures that the test is performed with geographical efficiency.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Market Segmentation
    4. Assumptions
  2. Preface
  3. Executive Summary
  4. Global Liquid Biopsy Market Venture Capital Ecosystem
    1. Financing By Key Investors
    2. Financing Recipient Wise Details
  5. Global Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Work Process
        1. Sample Preparation               
        2. Library Preparation
        3. Sequencing
        4. Data Analysis         
      2. By Technology
        1. PCR
          1. RT-PCR
          2. dPCR
          3. Multiplex PCR
          4. Others
        2. NGS
        3. FISH
        4. Other Technologies
      3. By Usage
        1. RUO
        2. Clinical
      4. By Sample Type
        1. Blood
        2. Urine
        3. Saliva
        4. Cerebrospinal Fluid
      5. By Products
        1. Test /Services
        2. Kits and Consumables
        3. Instruments
      6. By Circulating Biomarkers
        1. Circulating Tumor Cells
        2. Cell-free DNA
        3. Circulating Cell-Free RNA   
        4. Exosomes and Extracellular Vesicles           
        5. Others                     
      7. By Disease Type
        1. Lung Cancer
        2. Breast Cancer
        3. Prostate Cancer
        4. Colorectal Cancer
        5. Melanoma
        6. Other Cancers
        7. Non-Oncology Disorders
      8. By Clinical Application
        1. Treatment Monitoring
        2. Prognosis and Recurrence Monitoring
        3. Treatment Selection
        4. Diagnosis and Screening
      9. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia-Pacific
      10. By Company
        1. Competition Characteristics
        2. Market Share & Analysis
          1. 2018
          2. 2019
          3. 2020
        3. Competitive Matrix
  6. North America Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Technology
      2. By Usage
      3. By Sample Type
      4. By Products
      5. By Circulating Biomarkers
      6. By Disease Type
      7. By Clinical Applications
      8. By Country
        1. The US Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        2. Canada Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        3. Mexico Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
  7. South America Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Technology
      2. By Usage
      3. By Sample Type
      4. By Products
      5. By Circulating Biomarkers
      6. By Disease Type
      7. By Clinical Applications
      8. By Country
      9.  
      10. Brazil Liquid Biopsy Market Outlook, 2018-2028F
        1. Market Size & Analysis
          1. Revenues
        2. Market Share & Analysis
          1. By Product & Service
          2. By Circulating Biomarker
          3. By Technology
          4. By Sample Type
          5. By Application
          6. By Clinical Application
  8. Europe Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Technology
      2. By Usage
      3. By Sample Type
      4. By Products
      5. By Circulating Biomarkers
      6. By Disease Type
      7. By Clinical Applications
      8. By Country
        1. Germany Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        2. France Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        3. The United Kingdom Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        4. Italy Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        5. Spain Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
  9. Middle East & Africa Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Technology
      2. By Usage
      3. By Sample Type
      4. By Products
      5. By Circulating Biomarkers
      6. By Disease Type
      7. By Clinical Applications
      8. By Country
      9. Saudi Arabia Liquid Biopsy Market Outlook, 2018-2028F
        1. Market Size & Analysis
          1. Revenues
        2. Market Share & Analysis
          1. By Circulating Biomarkers
          2. By Disease Type
          3. By Clinical Applications
    3. UAE Liquid Biopsy Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Circulating Biomarkers
        2. By Disease Type
        3. By Clinical Applications
  10. South Africa Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Circulating Biomarkers
      2. By Disease Type
      3. By Clinical Applications
  11. Asia-Pacific Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Technology
      2. By Usage
      3. By Sample Type
      4. By Products
      5. By Circulating Biomarkers
      6. By Disease Type
      7. By Clinical Applications
      8. By Country
        1. China Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        2. India Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        3. Japan Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        4. South Korea Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        5. South East Asia Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
  12. Global Liquid Biopsy Market List of Biopsies Approved by The Governments
  13. Global Liquid Biopsy Market Policies, Regulations, Product Standards
    1. The United States
    2. European Union
  14.  Global Liquid Biopsy Market Intellectual Property Rights Insights
    1. Patent Portfolio of Leading Players
    2. Patent Filings, Registrations and Expiration
  15. Global Liquid Biopsy Market Trends & Insights
  16. Global Liquid Biopsy Market Dynamics
    1. Growth Drivers
    2. Challenges
    3. Impact Analysis
  17. Global Liquid Biopsy Market Hotspot & Opportunities
  18. Competition Outlook
    1. Competition Matrix
      1. Product/ Solution Portfolio
      2. Target Markets
      3. Target End Users
      4. Research & Development
      5. Strategic Alliances
      6. Strategic Initiatives
    2. Competitor Capability Matrix
      1. By Technology
      2. By Sample Type
      3. By Biomarker
      4. By Application
    3. Company Profiles of Top Companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
      1. Bio-Rad Laboratories
      2. Biocept Inc
      3. Abcodia Ltd
      4. Chronix Biomedical
      5. Epic Sciences Inc
      6. Hoffmann-La Roche AG  
      7. Cynvenio Biosystems, Inc.          
      8. GUARDANT HEALTH, INC  
      9. Illumina, Inc.
      10. NeoGenomics Laboratories, Inc.
      11. Menarini Silicon Biosystems, Inc.
      12. Qiagen N.V.
      13. Thermo Fisher Scientific
      14. Personal Genome Diagnostics, Inc.
      15.  Qiagen N.V.
  19. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Inquire Before Buying
Talk to our Consultant
Request Customization
Global / Regional Reports Global / Regional Reports
Report Walkthrough Report Walkthrough
Related Reports
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis